Literature DB >> 17264475

Sendai virus vector-mediated transgene expression in the cochlea in vivo.

Sho Kanzaki1, Akihiro Shiotani, Makoto Inoue, Mamoru Hasegawa, Kaoru Ogawa.   

Abstract

We injected a recombinant Sendai virus (SeV) vector into the guinea pig cochlea using two different approaches--the scala media and scala tympani--and investigated which cell types took up the vector. The hearing threshold shift and distribution of transfected cells in animals using the scala media approach were different compared to those using the scala tympani approach. SeV can transfect very different types of cells, including stria vascularis, spiral ganglion neurons, and sensory epithelia of the organ of Corti, and fibrocytes of the scala tympani. Because SeV vectors can potentially deliver stimuli to the cochlea to induce hair cell regeneration, it may be a powerful tool for repairing the organ of Corti. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17264475     DOI: 10.1159/000097798

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  13 in total

1.  Hyaluronic acid enhances gene delivery into the cochlea.

Authors:  Seiji B Shibata; Sarah R Cortez; James A Wiler; Donald L Swiderski; Yehoash Raphael
Journal:  Hum Gene Ther       Date:  2012-02-08       Impact factor: 5.695

Review 2.  Current status and prospects of gene therapy for the inner ear.

Authors:  Hong Sun; Aji Huang; Shousong Cao
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

Review 3.  Gene therapy for hearing loss.

Authors:  Ryotaro Omichi; Seiji B Shibata; Cynthia C Morton; Richard J H Smith
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

4.  Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.

Authors:  N Tanaka; K Araki; D Mizokami; Y Miyagawa; T Yamashita; M Tomifuji; Y Ueda; M Inoue; K Matsushita; F Nomura; H Shimada; A Shiotani
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

5.  A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.

Authors:  Olga Malykhina; Mark A Yednak; Peter L Collins; Paul D Olivo; Mark E Peeples
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

6.  Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.

Authors:  T Kurioka; K Mizutari; K Niwa; T Fukumori; M Inoue; M Hasegawa; A Shiotani
Journal:  Gene Ther       Date:  2015-09-11       Impact factor: 5.250

7.  Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.

Authors:  Andrew K Wise; Clifford R Hume; Brianna O Flynn; Yogesh S Jeelall; Courtney L Suhr; Beatrice E Sgro; Stephen J O'Leary; Robert K Shepherd; Rachael T Richardson
Journal:  Mol Ther       Date:  2010-03-09       Impact factor: 11.454

8.  Inner Ear Gene Delivery: Vectors and Routes.

Authors:  Chris Valentini; Betsy Szeto; Jeffrey W Kysar; Anil K Lalwani
Journal:  Hearing Balance Commun       Date:  2020-08-25

Review 9.  Gene and drug delivery system and potential treatment into inner ear for protection and regeneration.

Authors:  Sho Kanzaki
Journal:  Front Pharmacol       Date:  2014-10-08       Impact factor: 5.810

Review 10.  Practical aspects of inner ear gene delivery for research and clinical applications.

Authors:  Sungsu Lee; Anna Dondzillo; Samuel P Gubbels; Yehoash Raphael
Journal:  Hear Res       Date:  2020-03-06       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.